![](https://tracker.live.rns-distribution.com/track.live-rns/5136229_75d1671758db0ed18eba2dbba83793b2.png)
This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
10th April 2024
MicroSalt plc
("MicroSalt" or the "Company")
Placement of MicroSalt across the Carma Hospital Group (Montreal)
MicroSalt plc (AIM: SALT), a company commercialising a patented technology to produce full-flavour low-sodium salt, is pleased to announce its first placement into the [premium] food service sector, with Carma Hospitality Group ("Carma"), a chain of 12 restaurants across Montreal, Canada.
Rick Guiney, CEO of MicroSalt said: "Inclusion of our low sodium solution with the Carma Hospitality Group is a great endorsement of our ability to provide a low sodium yet tasty solution. It demonstrates the wide appeal of Microsalt and offers a real-world example of our potential in the foodservice channel. The restaurants within the Carma Hospitality Group represent some of the best food establishments in Montreal and we are extremely proud to be affiliated with their culinary team. We also expect that this [relationship with/endorsement by] Carma will result in other restauranteurs embracing our critically needed product."
Co-founder of Carma, Mike Zaki said: "Our use of Microsalt underscores our commitment to excellence, and innovation. We are proud of our ability to use leading technology applications in our kitchens to ensure the absolute best and unforgettable dining experiences."
About Carma Hospitality
Since 2016, an extraordinary hospitality group that brings a diverse range of culinary experiences to life in the Greater Montreal and Old Port areas. With over 10 distinct restaurants, each boasting its own unique ambiance and culinary expertise, Carma Hospitality invites you on a captivating journey through Italian delicacies, succulent seafood, vibrant Mexican flavors, sizzling steaks, refined Japanese omakase. Our commitment to excellence, innovation, and unforgettable dining experiences has made us a cornerstone of the Montreal culinary scene. https://carmahospitality.com/team/
For more information, please visit www.microsaltinc.co, follow on X @microSaltPLC or contact:
MicroSalt plc | Via Flagstaff PR |
Rick Guiney, CEO | |
| |
Flagstaff PR (Financial PR) | +44 (0)20 7129 1474 |
Tim Thompson / Alison Allfrey / Anna Probert microsalt@flagstaffcomms.com | |
Notes to Editors
MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.
MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.
Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.
The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.